Implementation research and child diarrhea

While considerable recent progress has been made against childhood diarrheal diseases, the number of children dying from diarrhoea remains unacceptably high.

This week, PLOS Medicine publishes a report based upon the work of over 150 international experts who convened to review and discuss research priorities to address this global problem. Zulfiqar Bhutta from the Aga Khan University in Pakistan and colleagues report that the most important priority is for more research on implementation of known interventions.

Research questions involving improving implementation, especially through behaviour change and other delivery strategies, ranked most highly during the experts' deliberations. Oral rehydration and were also seen as priorities, including research questions asking to identify driving factors of caregiver demand for oral rehydration solutions and zinc, and development of an ORS formulation that reduces stool output, were ranked highly.

The authors say that "in tandem with the Global Action Plan for and , concerted efforts by a range of stakeholders in implementation research will be needed to equitably scale up already proven, effective interventions."

More information: Wazny K, Zipursky A, Black R, Curtis V, Duggan C, et al. (2013) Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years. PLoS Med 10(5): e1001446. doi:10.1371/journal.pmed.1001446

add to favorites email to friend print save as pdf

Related Stories

Back pain researchers identify current priorities

Jan 30, 2013

(HealthDay)—Low back pain (LBP) primary care researchers indicate that the identification and management of specific subgroups of patients and translation of research into clinical practice should be the ...

Recommended for you

New research characterizes in-flight pediatric deaths

8 hours ago

In a first-of-its-kind study, researchers at University Hospitals Rainbow Babies & Children's Hospital (UH Rainbow) found that lap infants may be at greater risk for death on a commercial airline flight. The study analyzed ...

Virus drugmaker fights pediatricians' new advice

Jul 28, 2014

(AP)—A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the leading U.S. pediatrician's group, which recommends scaling back use of the medicine.

User comments